Elite Pharmaceuticals, Inc. ELTP Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Elite Pharmaceuticals, Inc. ELTP Company Overview 

Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt1=Go!

Elite Pharmaceuticals, Inc. ELTP Current Price and Quotes
Last Price 0.1098
Previous Close 0.10 Open 0.1072
Daily Range 0.11 - 0.1001 52wk Range 0.143 - 0.05
Volume 4,820,631 Dividend N/A
Average Vol (3m) 1,506,657 Yield N/A
Elite Pharmaceuticals, Inc. ELTP
Company Information

165 Ludlow Avenue
Northvale, NJ 07647

Website: http://www.elitepharma.com
Phone: 201-750-2646
Email: info@elitepharma.com

Elite Pharmaceuticals, Inc. ELTP
Elite Pharmaceuticals, Inc. ELTP
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001053369
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Nasrat Hakim President, CEO
Carter J. Ward CFO
Company Directors

Jerry I. Treppel Chairman
Service Providers

Auditor/Accountant
Demetrius Berkower LLC
Wayne Plaza II
155 Route 46 West
Wayne, NJ, 07470
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Elite Pharmaceuticals, Inc. ELTP
ELTP Security Details

Share Structure

Market Value1 $44,299,291 a/o Sep 13, 2013
Shares Outstanding 403,454,380 a/o Aug 09, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.01
Shareholders

Shareholders of Record 122 a/o Jun 21, 2013
Security Notes

Note = delisted from NYSE Alternext on 05/21/09
Short Selling Data

Short Interest 266,728 (-15.68%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Elite Pharmaceuticals, Inc. ELTP Recent News

Sept 3, 2013 Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
Aug 15, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014
Aug 13, 2013 Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013
Aug 12, 2013 Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Aug 7, 2013 OTC Daily Alert Stock Watch - Elite Pharmaceuticals, Inc. (OTCQB: ELTP)
Aug 5, 2013 Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer
Jun 21, 2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History
Jun 19, 2013 Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013


Elite Pharmaceuticals, Inc. ELTP Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 3,404 2,424 4,266 3,344
Cost of Revenue 2,315 1,014 2,675 2,306
Gross Profit 1,088 1,410 1,591 1,039
Operating Expenses

Research and Development 975 1,736 1,385 794
Sales, General and Admin. 1,559 1,435 918 1,966
Non-Recurring Items - - - -
Other 117 206 173 214
Operating Income (1,563) (1,966) (886) (1,936)
Income From Continuing Operations

Add'l Income/Expense Items 3,090 (12,922) (11,507) (4,589)
Earnings Before Interest and Tax 1,527 (14,888) (12,392) (6,786)
Interest Expense 393 654 1,491 1,271
Earnings Before Tax 1,134 (15,542) (13,884) (8,057)
Income Tax (354) (484) (301) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 1,488 (15,058) (13,582) (8,057)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,488 (15,058) (13,582) (8,057)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,488 (15,058) (13,582) (8,057)

ELTP Elite Pharmaceuticals, Inc. Research DD Guide

ELTP Elite Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=ELTP&...mp;yt0=Go!
ELTP Elite Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/ELTP/quote
ELTP Elite Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/ELTP/chart
ELTP Elite Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/ELTP/company-info
ELTP Elite Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/ELTP/news
ELTP Elite Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/ELTP/financials
ELTP Elite Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/ELTP/filings
ELTP Elite Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/ELTP/short-sales
ELTP Elite Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/ELTP/insider-transactions
ELTP Elite Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/ELTP/research
ELTP Elite Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=ELTP
ELTP Elite Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=ELTP+Historical+Prices
ELTP Elite Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=ELTP
ELTP Elite Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=ELTP+Basic+Chart
ELTP Elite Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ELTP+Basic+Tech.+Analysis
ELTP Elite Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=ELTP+Headlines
ELTP Elite Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=ELTP+Press+Releases
ELTP Elite Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=ELTP+Profile
ELTP Elite Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=ELTP+Key+Statistics
ELTP Elite Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=ELTP+Industry
ELTP Elite Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=ELTP+Major+Holders
ELTP Elite Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=ELTP+Insider+Transactions
ELTP Elite Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=ELTP+Insider+Roster
ELTP Elite Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=ELTP
ELTP Elite Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=ELTP
ELTP Elite Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=ELTP+Cash+Flow&annual
ELTP Elite Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/ELTP
ELTP Elite Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/ELTP
ELTP Elite Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/ELTP:US
ELTP Elite Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=ELTP
ELTP Elite Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=ELTP
ELTP Elite Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/ELTP
ELTP Elite Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=ELTP
ELTP Elite Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/ELTP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading